SCYNEXIS, Inc. (NASDAQ:SCYX)

About the company

SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

27

CEO

Marco Taglietti

Exchange

NASDAQ

Website

http://www.scynexis.com

$0.00M

Total Revenue

27

Employees

$48.95M

Market Capitalization

-1.26

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12030.90 1376.00 5.13 18.97 43.06
Catalent, Inc. CTLT 10896.37 2872.00 5.47 104.47 3.63
Perrigo Co. Plc PRGO 7525.41 4837.00 1.29 51.34 3.02
Bausch Health Cos., Inc. BHC 6195.15 8597.00 8.65 -3.27 -21.96
Jazz Pharmaceuticals Plc JAZZ 6129.78 2188.00 2.12 22.40 12.81
United Therapeutics Corp. UTHR 5064.54 1443.00 1.76 9.77 36.59
MyoKardia, Inc. MYOK 4325.84 34.00 12.57 -13.95 -201.73
Axsome Therapeutics, Inc. AXSM 3004.40 None 20.39 -33.40 None
Pacira Biosciences, Inc. PCRX 2374.68 435.00 6.37 -5654.00 -0.02
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
SAGE Therapeutics, Inc. SAGE 2181.92 9.00 2.56 -3.37 -413.06
Corcept Therapeutics, Inc. CORT 2043.50 335.00 4.69 19.25 31.64
Prestige Consumer Healthcare, Inc. PBH 1862.52 963.00 1.57 13.14 14.77
Madrigal Pharmaceuticals, Inc. MDGL 1617.30 0.00 4.32 -15.83 -624.74
Revolution Medicines, Inc. RVMD 1581.20 48.00 4.10 -22.33 -146.29
Ironwood Pharmaceuticals, Inc. IRWD 1548.02 440.00 -21.91 18.26 19.14
Innoviva, Inc. INVA 1539.06 285.00 3.64 7.96 66.41
Intercept Pharmaceuticals, Inc. ICPT 1409.60 272.00 -41.95 -4.11 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Supernus Pharmaceuticals, Inc. SUPN 1274.94 402.00 2.02 10.93 28.90
Zogenix, Inc. ZGNX 1272.60 5.00 3.47 -2.99 -241.62
Revance Therapeutics, Inc. RVNC 1230.46 0.00 4.86 -6.59 41.82
Theravance Biopharma, Inc. TBPH 1220.94 88.00 -8.57 -4.95 -280.80
Amphastar Pharmaceuticals, Inc. AMPH 1020.18 327.00 2.55 20.02 15.90
Endo International Plc ENDP 777.48 3014.00 -1.06 -2.77 -9.09
BellRing Brands, Inc. BRBR 745.68 954.00 -0.40 5.66 13.98
Assembly Biosciences, Inc. ASMB 680.34 16.00 3.05 -6.84 -601.75
Eagle Pharmaceuticals, Inc. EGRX 648.90 192.00 3.49 257.50 1.29
Aerie Pharmaceuticals, Inc. AERI 616.86 79.00 4.89 -3.05 -252.92
Collegium Pharmaceutical, Inc. COLL 582.76 299.00 4.17 -45.11 -4.21
Catalyst Pharmaceuticals, Inc. CPRX 536.07 119.00 5.22 12.22 36.09
Anika Therapeutics, Inc. ANIK 494.20 125.00 1.71 17.83 22.73
Intersect ENT, Inc. XENT 445.76 102.00 4.21 -8.93 -48.61
BioDelivery Sciences International, Inc. BDSI 392.84 130.00 5.62 -53.37 -5.01
ANI Pharmaceuticals, Inc. ANIP 367.56 203.00 1.88 -235.62 -0.67
Albireo Pharma, Inc. ALBO 331.24 11.00 3.37 -4.33 -730.55
MEI Pharma, Inc. MEIP 288.01 5.00 4.96 -7.38 -539.48
Mallinckrodt Plc MNK 199.08 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 161.66 None 2.63 -7.83 None
Marinus Pharmaceuticals, Inc. MRNS 151.20 0.00 5.85 -2.24 None
Cerecor, Inc. CERC 119.60 7.00 7.65 -5.31 -429.22
Ampio Pharmaceuticals, Inc. AMPE 98.38 1.00 68.80 -5.29 None
Evoke Pharma, Inc. EVOK 85.92 None 29.83 -12.79 None
AcelRx Pharmaceuticals, Inc. ACRX 85.60 2.00 -1.57 -1.53 -644.25
CTI BioPharma Corp. CTIC 83.78 3.00 3.74 -2.03 -111.83
Zynerba Pharmaceuticals, Inc. ZYNE 78.66 0.00 1.29 -2.19 -699.94
Aclaris Therapeutics, Inc. ACRS 73.80 4.00 1.29 -0.54 None
Adamas Pharmaceuticals, Inc. ADMS 70.84 57.00 -4.52 -0.76 -160.44
Oramed Pharmaceuticals, Inc. ORMP 61.02 3.00 4.91 -4.77 -464.15
Cassava Sciences, Inc. SAVA 56.62 41.00 2.98 -12.42 76.71
Cumberland Pharmaceuticals, Inc. CPIX 49.20 47.00 1.00 -10.93 -9.59
SCYNEXIS, Inc. SCYX 48.95 0.00 10.28 -1.26 -30.84
Natural Alternatives International, Inc. NAII 47.67 114.00 0.65 -12.61 -3.19
IsoRay, Inc. ISR 46.90 9.00 8.75 -14.00 -36.08
Lipocine, Inc. LPCN 39.90 0.00 9.50 -2.66 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.50 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 25.88 0.00 -2.48 -2.74 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 20.80 3.00 2.59 -1.76 -264.21
Regulus Therapeutics, Inc. RGLS 17.49 0.00 1.54 -0.82 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.65 8.00 0.67 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.18 None 1.31 -0.24 None
Hepion Pharmaceuticals, Inc. HEPA 7.38 None 2.31 -0.62 None
VIVUS, Inc. VVUS 6.88 73.00 -0.15 -0.23 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 6.35 19.00 1.01 -2.04 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Tonix Pharmaceuticals Holding Corp. TNXP 4.62 None 1.16 -0.10 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

SCYNEXIS to Host A Key Opinion Leader Discussion on the Immediate Need in Treating Women with Vaginal Yeast Infections

3h ago, source: YAHOO!

Discussion will be conducted via Webcast Call on Tuesday, July 14th at 10am Eastern Time Event will highlight the impact of vaginal yeast infections on women, the.

Financials SCYNEXIS

10d ago, source: Business Insider

© 2020 Insider Inc. and finanzen.net GmbH All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy ...

SCYNEXIS Inc (SCYX): Are Hedge Funds Right About This Stock?

1mon ago, source: Insider Monkey

In this article we will take a look at whether hedge funds think SCYNEXIS Inc (NASDAQ:SCYX) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving ...

Calyxt promotes current director and biotechnology exec Yves Ribeill to chairman

2d ago, source: Proactiveinvestors

Ribeill founded the biotechnology company SCYNEXIS Inc (NASDAQ:SCYX) and served as its CEO from 1999 to 2015. He currently heads Ribogenics Inc, an early stage R&D company. All told, he brings more ...

SCYNEXIS Inc.

21d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Calyxt Announces Board Changes

3d ago, source: Business Wire

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced the appointment of current board member Yves Ribeill, Ph.D., as Chairman. Thi ...

SCYNEXIS Reports Full Year 2019 Financial Results and Provides Company Update

19d ago, source: Bloomberg

Before it's here, it's on the Bloomberg Terminal.



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.